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Auditory neuropathy (AN) is a hearing disorder char-
acterized by absence of auditory brainstem responses de-
spite preservation of outer hair cell function, and has at-
tracted attentions from researchers and audiologists since
reported by Starr et al [1]. Clinical manifestations in AN
patients include abnormal auditory brainstem responses,
normal otoacoustic emissions, lack of acoustic reflexes,
large cochlear microphonics, speech perception deteriora-
tion worse than expected based on the audiogram, especial-
ly in noise, fluctuating sensorineural hearing loss, etc [2, 3].
Because of the uncertainty of site-of-lesions, treatment
of AN is yet to be standardized and faced with great chal-
lenges. Conventional acoustic hearing aids (HA) and
medical treatment have failed to show any proved bene-
fit. Cochlear implantation (CI) is considered a unique op-
tion in the treatment of AN, although its efficacy is diffi-
cult to predict before surgery [4]. This article is going to
give a brief review of the historical evolution and current
status of CI as an intervention in patients with AN.
Contraindication with hopes
When AN was identified in the 1990’s, the disease was
simply thought to be due to neural degeneration, with com-
promised neural activities across nerve fibers [1]. AN was
then reasonably thought to be a contraindication for CI.
Some pilot studies yielded results supporting this notion.
Miyamoto et al reported the earliest case of CI in a child
with AN, with limited improvement in both phoneme
and word recognition [5].
Meanwhile, some positive evidence from animal ex-
periments was reported, which encouraged people to
treat AN patients with CI. Zhou et al [6] recorded measur-
able electrically evoked auditory brainstem response
(EABR) waveforms in peripherally myelin-deficient
mice. Araki et al [7] demonstrated that chronic electrical
stimulation may help the survival of spiral ganglions. In
addition, electrical stimulation was found to be more pre-
cise in evoking nerve response than acoustic stimulation [8],
suggesting that cochlear implants could improve synchro-
nization in neural conduction by electrical stimulation.
Twilight proofs
In a case report from Trautwein et al, evident electri-
cal auditory brainstem responses (EABRs) were record-
ed after implantation in a child with AN, with significant
improvement in speech perception [9]. Shallop et al [10] and
Peterson et al [11] reported the preliminary results from a
group of AN children implanted at Mayo Clinic in Roch-
ester, Minnesota. These children showed significant post-
operative improvement in sound detection, speech per-
ception and communication, with no difference in CI
benefits compared with other CI recipients. Buss et al [12]
reported 4 children with AN who had failed to benefit
from amplification trials before implantation. All sub-
jects’performance data were comparable with other pe-
diatric implant patients using the Paden-Brown test at
the 1-year follow-up, with two out of the four better than
control subjects, while all subjects showed robust contra-
lateral reflex and EABR wave V, suggesting synchro-
nous neural response to stimulation delivered through
the implant. In a study implemented by Zeng et al. [13],
speech intelligibility was compared in 7 AN patients be-
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tween CI and acoustic HA in both quiet and in noise con-
ditions. The former produced significantly higher intelli-
gibility than the latter and reached the level of SNHL
controls. Raveh et al. [14] reported better speech recogni-
tion performance in 12 AN patients with CI than those
with HA. They thereby advocated CI as often a good so-
lution for failures of conventional rehabilitation. In the
evaluation on speech production in some children, Mean-
ingful Use of Speech Scale (MUSS) results demonstrat-
ed an improvement from 3% preoperatively to 29% post-
operatively. Jeong et al. [15] reported optimistic implanta-
tion results in 9 children with AN whose performance
outcomes are as good as those children implanted for
sensorineural hearing loss. No statistically significant dif-
ferences were found between AN implanted children and
matched SNHL implanted children in performance out-
comes including Categories of Auditory Performance
scale (CAP, P=0.3337), Monosyllabic Word test for pho-
nemes (MW, P=0.5768) and Common Phrases test (P=
0.3337). Besides, slopes of electrically evoked com-
pound action potentials (ECAPs) amplitude growth func-
tions were also similar (P=0.970) in the two groups, dem-
onstrating comparable spiral ganglion populations.
Rance et al. [16] evaluated speech perception skills in chil-
dren with AN fitted with cochlear implants by open-set
CNC monosyllabic words. In 10 implanted AN children,
9 demonstrated significant speech discrimination improve-
ment in phoneme recognition (P=0.006) with scores no
less than 55%, which were similar with the results in the
amplification aided AN group although poorer than
those in the matched control group implanted for sensori-
neural hearing loss .
Effective with variable results
Some studies with larger samples published in recent
years demonstrated relative optimistic results. Gibson [17]
reported a sample of 60 diagnosed AN children with CI.
Round window electro- cochleography (RWECochG),
EABR and the Melbourne speech perception scores
(MSPS) were employed to evaluate the results. Of the
subjects that had abnormal positive potential (APP) in
RWECochG, 75% had normal EABRs and demonstrated
better performance with CI than the control group, while
the rest 25% with abnormal APP and EABRs benefited
little from CIs. Walton et al. [18] compared AN children
with normal cochlear nerve function to those with co-
chlear nerve deficiency (CND) (n=54). At 1 year postop-
eratively, the CND group performed significantly worse
in both MSPS and EABR than the normal cochlear nerve
group, indicating the necessity of screening CND before
implantation. Results from Teagle et al. [19] led to a con-
clusion that CI is effective for most of the AN children.
In their study, half of the implanted AN children demon-
strated open-set speech perception abilities, with mean
PBK scores of words and phonemes improved by 40%
and 27% respectively. Another 29% of the subjects who
were too young to participate in speech audiometry
showed postoperative improvement in IT-MAIS scores by
around 53% . Meanwhile, children with CND could not
achieve open-set speech perception abilities. These results
were consistent with the study by Breneman et al. [26]. In
their retrospective study, 35 AN children with CIs were
matched on age at activation and months of implant use
at each postoperative evaluation point with their SNHL
peers. On the premise that children with CND be exclud-
ed, there was no difference between groups in long-term
outcomes of monosyllabic and multisyllabic recognition
test, Glendonald Auditory Screening Procedure (GASP)
word recognition test, questionnaire of LittlEARS or
MAIS. This was the most optimistic results regarding
the outcomes of CI in AN children up to date. Great con-
fidence and enthusiasm for CI in appropriately selected
patients were gained through these successful experienc-
es. In the position statement of the Joint Committee on
Infant Hearing (JCIH 2007), CI was advocated to be giv-
en careful consideration for any child who suffers from
AN and experiences limited benefit from hearing aids [4].
In 2008, Guidelines and Development Conference on the
Identification and Management of Children with Audito-
ry Neuropathy in Como, Italy, came to a consensus that
CI be considered as an option for AN patients if progress
in auditory language development has been poor, regard-
less of behavioral audiometric threshold [20]. However, it
should be noted that not all AN patients benefit from CI.
In studies where CIs demonstrated statistically signifi-
cant benefit on AN patients, the outcomes showed large
variety among AN individuals [4, 19,21]. Some studies report-
ed poor postoperative performance in AN subjects, espe-
cially in those with syndromic AN [22, 23]or CND [18,21].
China Status
In China, some case reports on CI in AN patients have
appeared in the past 5 years. Chen Yang et al. [24] ana-
lyzed the efficacy of CI in 2 AN patients using ECAP and
word recognition. The results indicated that one
two-year-oldAN girl demonstrated good ECAPwaveforms
and better word recognition score than before implanta-
tion; while the other case, a eighteen-year-old postlin-
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gual deaf man, showed absent ECAPs and poor recogni-
tion score even after hearing rehabilitation training. JI
Fei et al. [25] assessed the efficacy of CI on a 4-year-old
boy with AN. The boy demonstrated improved auditory
sensitivity through using CI. Concerning speech recogni-
tion and communication, both speech audiometry and
questionnaires showed an obvious benefit from CI.
A brief summary of CI in AN patients is presented in
Table 1.
Efficacy evaluation
A great diversity in manifestation, age of onset, etiolo-
gy, pathogenesis, site of lesion, etc. in AN individuals
leads to variable and unpredictable postoperative perfor-
mances. It can be found in aforementioned studies that
variable conclusions were drawn from different research
protocols or methods on the efficacy of CI in AN pa-
tients. To determine whether AN patients can benefit
from CI, different criteria have been implemented in dif-
ferent studies. To sum up, results indicating positive effi-
cacy include: (a) improved hearing thresholds over
speech frequencies [11]; (b) elicitation of electrophysiologi-
cal response such as EABRs, ECAPs, or electrical stape-
dius reflexes (ESRs) [9,10,11]; and (c) improvement in
speech recognition[13,15,16,17,19,26,28,29]. Many studies combine
these three categories of criteria to evaluate CI efficacy
in patients of AN in more comprehensive ways [11,28]. How-
ever, it should be noted that hearing loss is not the prima-
ry impairment in AN patients. The main functional im-
pairment in AN is difficulty in speech recognition, espe-
cially in noisy environment. In fact, almost all AN pa-
tients obtain improved hearing thresholds from CI[4].
There has been no definite evidence supporting the rela-
tionship between electrically evoked auditory pathway
responses and speech performances. The most direct and
appropriate methods to evaluate the benefit of CI in AN
patients are methods related to speech recognition. These
methods can be either open-set or close-set speech recog-
nition tests, or questionnaires / scales appropriate for the
level of language development and the capability of AN
patients in conducting the tests. The former include CNC
monosyllabic words test[16], Paden-Brown phonological
kit [12], Hearing in Noise Test (HINT) [13], MSPS [17,18],
GASP [30], Common Phrases test [15], etc.; and the latter in-
Year
2000
2001
2002
2003
2003
2006
2007
2007
2007
2008
2008
2008
2010
2011
2012
Researcher
Trautwein et al.[9]
Shallop et al.[10]
Buss et al.[12]
Peterson et al.[11]
Mason et al.[26]
Zeng FG et al.[13]
Jeong et al.[15]
Raveh et al.[14]
Gibson et al.[17]
Rance et al.[16]
De Leenheer et al.[27]
Chen Y et al. [24]
Teagle et al.[19]
JI F et al. [25]
Breneman et al.[34]
N
1
5
4
10
4
7
6
12
60
10
3
2
52
1
35
Results
EABR was evident following implantation
The five children had no postoperative complications, and showed improved listening and
communication skills
Speech data were comparable with those obtained from the general CI children, and Identifiable
EABRs were obtained
No differences in CI benefit between AN and SNHL groups
Patients with CIs demonstrated EABRs and improved audiological performance.
Speech intelligibility in 7 AN patients reached the level of SNHL controls
No significant differences between ANs and SNHLs in performance outcomes and the slopes of ECAP
amplitude growth functions
Better speech recognition performance with CIs than HAs.
45 out of 60 AN subjects demonstrated better performance than control group
9 out of 10 implanted AN children demonstrated improvement in phoneme recognition, poorer than
SNHL controls
CI was successful in 2 out of 3 AN cases
One prelingual AN child showed good performance, the other postlingual adult had poor performance
41 patients obtained improvement in speech recognition
The subject demonstrated improved auditory sensitivity, speech recognition and communication skills.
Expected outcomes of CI for children with AN are no different than for children with non-AN SNHL,
excluding children with CND
Table 1 Literature reports on CI in AN patients
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clude MAIS/ IT-MAIS[11,19,30], MUSS[14], CAP [15] and Lit-
tlEARS [30]. Quantified comparison can be made between
pre- and post-operative performances[16,19,29], between AN
patients treated with CI and those with hearing aids [14], or
between AN patients and matched SNHL peers[13,15,17,26,28].
The diversity of speech performance tools used may lead
to different conclusions.
Future Research Needs
AN has drastic complexity and variety in mechanisms,
lesion site, and pathology, which drives the unpredictabil-
ity of CI as an intervention in patients with AN [4]. From
this review it can be readily seen that audibility in AN pa-
tients can be restored by CI, while the postoperative
speech performance varies drastically among individu-
als. There is no reliable relationship established between
the effect of CI and clinical characteristics of AN so far.
Possible future research directions may include:
1) More specific and detailed research about the mech-
anisms of AN are needed, and diagnostic methods based
on genetic, electrophysiological and psychophysical tests
are needed to locate AN impairment site before CI.
2) Well controlled prospective research is needed to
demonstrate the efficacy of CI in patients with AN.
3) Besides the improvement in audibility and speech
performance, advanced evaluation in speech production,
language skills, study skills and social communication
abilities should be done in AN patients especially in
pre-lingual AN children to demonstrate long term CI ben-
efits in this special group.
4) Individualized treatment in AN patients should be
advocated in the future. A multi-factor study about CI ef-
ficacy in AN patients is needed. Many factors including
opportunity of implantation, auditory nerve develop-
ment, speech ability before implantation, rehabilitation
mode, and hearing aids etc. need to be included in such a
study to provide more information in guiding an individ-
ual treatment plan.
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